{
    "id": 10691,
    "fullName": "ROS1 G1971E",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ROS1 G1971E lies within the protein kinase domain of the Ros1 protein (UniProt.org). G1971E has been demonstrated to confer resistance to Ros1 tyrosine kinase inhibitors in the context of a Ros1 fusion in culture (PMID: 24218589), but has not been biochemically characterized and therefore, its effect on Ros1 protein function is unknown (PubMed, Feb 2020).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6098,
        "geneSymbol": "ROS1",
        "terms": [
            "ROS1",
            "c-ros-1",
            "MCF3",
            "ROS"
        ]
    },
    "variant": "G1971E",
    "createDate": "08/17/2015",
    "updateDate": "02/21/2020",
    "referenceTranscriptCoordinates": {
        "id": 102338,
        "transcript": "NM_002944",
        "gDna": "chr6:g.117319896C>T",
        "cDna": "c.5912G>A",
        "protein": "p.G1971E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2809,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells overexpressing ROS1 G1971E in the context of GOPC-ROS1 (referred to as FIG-ROS1) were resistant to Xalkori (crizotinib)-mediated growth inhibition in culture (PMID: 24218589).",
            "molecularProfile": {
                "id": 10698,
                "profileName": "GOPC - ROS1 ROS1 G1971E"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2815,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Foretinib (GSK1363089) inhibited growth of transformed cells expressing ROS1 G1971E in the context of GOPC-ROS1 (referred to as FIG-ROS1) in culture (PMID: 24218589).",
            "molecularProfile": {
                "id": 10698,
                "profileName": "GOPC - ROS1 ROS1 G1971E"
            },
            "therapy": {
                "id": 743,
                "therapyName": "Foretinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3476,
                    "pubMedId": 24218589,
                    "title": "Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24218589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10697,
            "profileName": "ROS1 G1971E",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 10698,
            "profileName": "GOPC - ROS1 ROS1 G1971E",
            "profileTreatmentApproaches": [
                {
                    "id": 16945,
                    "name": "Foretinib",
                    "profileName": "GOPC - ROS1 ROS1 G1971E"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 102337,
            "transcript": "XM_011536050",
            "gDna": "chr6:g.117319923C>T",
            "cDna": "c.5912G>A",
            "protein": "p.G1971E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 102336,
            "transcript": "XM_017011173",
            "gDna": "chr6:g.117318238_117318239delACinsCT",
            "cDna": "c.5912_5913delGTinsAG",
            "protein": "p.G1971E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 102338,
            "transcript": "NM_002944",
            "gDna": "chr6:g.117319896C>T",
            "cDna": "c.5912G>A",
            "protein": "p.G1971E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}